Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


17.12.2018

3 Biol Psychiatry
2 Clin Neuropharmacol
2 Compr Psychiatry
1 J Clin Psychiatry
2 Mol Psychiatry
2 PLoS One
13 Psychiatry Res
20 Schizophr Res
2 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. BROWN R, Zandi MS
    Evaluating Associations Between Non-neuronal Autoimmune Disorders and Psychosis.
    Biol Psychiatry. 2019;85:8-9.
    PubMed     Text format    

  2. MURPHY CE, Walker AK, Shannon Weickert C
    Where There's Smoke, There's Fire-But Who Is Lighting the Match? Bolstering Transcriptional Evidence for the Role of Nuclear Factor-kappaB in Neuroimmune Activation in Schizophrenia.
    Biol Psychiatry. 2019;85:5-7.
    PubMed     Text format    

  3. LYALL AE, Rathi Y, Kubicki M, Shenton ME, et al
    Diffusion Magnetic Resonance Imaging Advances the Study of Nuclei-Specific Thalamocortical Connectivity in Early Stage Psychosis.
    Biol Psychiatry. 2019;85:10-12.
    PubMed     Text format    


    Clin Neuropharmacol

  4. KAPULSKY L, Brody BD
    Urinary Retention Associated With Cariprazine: A Case Report.
    Clin Neuropharmacol. 2018;41:230-231.
    PubMed     Text format     Abstract available

  5. REY MV, Molina L, Recinos B, Paz B, et al
    Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders.
    Clin Neuropharmacol. 2018;41:177-180.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  6. NG SM, Yeung CH, Gao S
    A concise self-report scale can identify high expressed emotions and predict higher relapse risk in schizophrenia.
    Compr Psychiatry. 2018;89:1-6.
    PubMed     Text format     Abstract available

  7. VAN DER MERWE C, Passchier R, Mufford M, Ramesar R, et al
    Polygenic risk for schizophrenia and associated brain structural changes: A systematic review.
    Compr Psychiatry. 2018;88:77-82.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  8. KUMAGAI F, Suzuki T, Fleischhacker WW, Yasui-Furukori N, et al
    Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs.
    J Clin Psychiatry. 2018;80.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  9. BERGMAN O, Karry R, Milhem J, Ben-Shachar D, et al
    NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia.
    Mol Psychiatry. 2018 Dec 10. pii: 10.1038/s41380-018-0309.
    PubMed     Text format     Abstract available

  10. REAY WR, Atkins JR, Quide Y, Carr VJ, et al
    Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtype.
    Mol Psychiatry. 2018 Dec 7. pii: 10.1038/s41380-018-0305.
    PubMed     Text format     Abstract available


    PLoS One

  11. HAGEN CM, Goncalves VF, Hedley PL, Bybjerg-Grauholm J, et al
    Schizophrenia-associated mt-DNA SNPs exhibit highly variable haplogroup affiliation and nuclear ancestry: Bi-genomic dependence raises major concerns for link to disease.
    PLoS One. 2018;13:e0208828.
    PubMed     Text format     Abstract available

  12. JIANG WJ, Zhong BL, Liu LZ, Zhou YJ, et al
    Reliability and validity of the Chinese version of the Childhood Trauma Questionnaire-Short Form for inpatients with schizophrenia.
    PLoS One. 2018;13:e0208779.
    PubMed     Text format     Abstract available


    Psychiatry Res

  13. KELLY BD, Duffy RM, Curley A
    Which involuntary admissions are revoked by mental health tribunals? A report from the Dublin Involuntary Admission Study (DIAS).
    Psychiatry Res. 2018;262:583-585.
    PubMed     Text format     Abstract available

  14. ROMINGER C, Schulter G, Fink A, Weiss EM, et al
    Meaning in meaninglessness: The propensity to perceive meaningful patterns in coincident events and randomly arranged stimuli is linked to enhanced attention in early sensory processing.
    Psychiatry Res. 2018;263:225-232.
    PubMed     Text format     Abstract available

  15. CONSTANTINE RJ, Andel R, McPherson M, Tandon R, et al
    Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
    Psychiatry Res. 2018;263:238-244.
    PubMed     Text format     Abstract available

  16. HJARPE J, Soderman E, Andreou D, Sedvall GC, et al
    No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Psychiatry Res. 2018;263:30-34.
    PubMed     Text format     Abstract available

  17. DUNCAN MJ, Arbour-Nicitopoulos K, Subramaniapillai M, Remington G, et al
    Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing sitting time among individuals with schizophrenia.
    Psychiatry Res. 2018;271:311-318.
    PubMed     Text format     Abstract available

  18. MCLEAN RT, Halley L, Clair DS, Wei J, et al
    No correlation between HLA-DQ 2.5, DQ 8.1 and DQ 6.2 and circulating levels of antibodies against gliadins in schizophrenia.
    Psychiatry Res. 2018;271:325-327.
    PubMed     Text format     Abstract available

  19. STRALIN P, Skott M, Cullberg J
    Early recovery and employment outcome 13 years after first episode psychosis.
    Psychiatry Res. 2018;271:374-380.
    PubMed     Text format     Abstract available

  20. HOFER A, Post F, Pardeller S, Frajo-Apor B, et al
    Self-stigma versus stigma resistance in schizophrenia: Associations with resilience, premorbid adjustment, and clinical symptoms.
    Psychiatry Res. 2018;271:396-401.
    PubMed     Text format     Abstract available

  21. RHEE TG, Rosenheck RA
    Does improvement in symptoms and quality of life in chronic schizophrenia reduce family caregiver Burden?
    Psychiatry Res. 2018;271:402-404.
    PubMed     Text format     Abstract available

  22. LI AWY, Hui CLM, Lee EHM, Chang WC, et al
    Gender differences in correlates of cognition in first-episode psychosis.
    Psychiatry Res. 2018;271:412-420.
    PubMed     Text format     Abstract available

  23. SWETS M, van Dijk FA, Schirmbeck F, Peen J, et al
    Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study.
    Psychiatry Res. 2018;271:421-427.
    PubMed     Text format     Abstract available

  24. BOSIA M, Bechi M, Bosinelli F, Politi E, et al
    From cognitive and clinical substrates to functional profiles: Disentangling heterogeneity in schizophrenia.
    Psychiatry Res. 2018;271:446-453.
    PubMed     Text format     Abstract available

  25. MAK M, Samochowiec J, Frydecka D, Pelka-Wysiecka J, et al
    First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood.
    Psychiatry Res. 2018;271:459-463.
    PubMed     Text format     Abstract available


    Schizophr Res

  26. TAKAHASHI T, Nakamura M, Sasabayashi D, Nishikawa Y, et al
    Reduced pineal gland volume across the stages of schizophrenia.
    Schizophr Res. 2018 Dec 4. pii: S0920-9964(18)30683.
    PubMed     Text format     Abstract available

  27. HOLMEN TL, Engh JA, Andersen E, Andreassen OA, et al
    Cardio-respiratory fitness is associated with a verbal factor across cognitive domains in schizophrenia.
    Schizophr Res. 2018 Dec 7. pii: S0920-9964(18)30684.
    PubMed     Text format     Abstract available

  28. LASKARIS L, Zalesky A, Weickert CS, Di Biase MA, et al
    Investigation of peripheral complement factors across stages of psychosis.
    Schizophr Res. 2018 Dec 5. pii: S0920-9964(18)30686.
    PubMed     Text format     Abstract available

  29. MCARDLE PA, De Mel V, DeMonte V, Winckel K, et al
    An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia.
    Schizophr Res. 2018 Dec 5. pii: S0920-9964(18)30679.
    PubMed     Text format    

  30. BRINK M, Green A, Bojesen AB, Lamberti JS, et al
    Excess medical comorbidity and mortality across the lifespan in schizophrenia.: A nationwide Danish register study.
    Schizophr Res. 2018 Dec 5. pii: S0920-9964(18)30622.
    PubMed     Text format     Abstract available

  31. STEINERT T
    Clinicians should better invest in de-escalation than in fish-oil to prevent violence.
    Schizophr Res. 2018;195:567.
    PubMed     Text format    

  32. SHEN A, Zhao W, Han B, Zhang Q, et al
    The contribution of the contingent negative variation (CNV) to goal maintenance.
    Schizophr Res. 2018;195:372-377.
    PubMed     Text format     Abstract available

  33. GOETZ RL, Miller BJ
    Meta-analysis of ghrelin alterations in schizophrenia: Effects of olanzapine.
    Schizophr Res. 2018 Dec 7. pii: S0920-9964(18)30687.
    PubMed     Text format     Abstract available

  34. SPANGARO M, Bosia M, Bechi M, Buonocore M, et al
    Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism.
    Schizophr Res. 2018;202:106-110.
    PubMed     Text format     Abstract available

  35. BERGER P, Bitsch F, Nagels A, Straube B, et al
    Frontal hypoactivation and alterations in the reward-system during humor processing in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2018;202:149-157.
    PubMed     Text format     Abstract available

  36. DENG Y, Liu K, Cheng D, Zhang J, et al
    Ventral and dorsal visual pathways exhibit abnormalities of static and dynamic connectivities, respectively, in patients with schizophrenia.
    Schizophr Res. 2018 Dec 10. pii: S0920-9964(18)30693.
    PubMed     Text format     Abstract available

  37. BANERJEE N, Polushina T, Bettella F, Steen VM, et al
    Analysis of differentially methylated regions in great apes and extinct hominids provides support for the evolutionary hypothesis of schizophrenia.
    Schizophr Res. 2018 Dec 10. pii: S0920-9964(18)30676.
    PubMed     Text format     Abstract available

  38. PEREZ SM, Donegan JJ, Boley AM, Aguilar DD, et al
    Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.
    Schizophr Res. 2018 Dec 3. pii: S0920-9964(18)30636.
    PubMed     Text format     Abstract available

  39. MORGAN VA, Clark M, Crewe J, Valuri G, et al
    Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study.
    Schizophr Res. 2018;202:414-416.
    PubMed     Text format     Abstract available

  40. POON YPY, Kan CK, Yeung WF, Chung KF, et al
    Delayed sleep-wake phase disorder and delayed sleep-wake phase in schizophrenia: Clinical and functional correlates.
    Schizophr Res. 2018;202:412-413.
    PubMed     Text format    

  41. YUEN HP, Mackinnon A, Hartmann J, Amminger GP, et al
    Dynamic prediction of transition to psychosis using joint modelling.
    Schizophr Res. 2018;202:333-340.
    PubMed     Text format     Abstract available

  42. DETORE NR, Ventura J, Subotnik KL, Nuechterlein KH, et al
    Family burden predicts functional outcome in the early course of schizophrenia beyond psychiatric symptoms and baseline functioning.
    Schizophr Res. 2018;202:328-332.
    PubMed     Text format     Abstract available

  43. RUBIN LH, Li S, Yao L, Keedy SK, et al
    Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.
    Schizophr Res. 2018;202:173-179.
    PubMed     Text format     Abstract available

  44. WOODWARD ML, Gicas KM, Warburton DE, White RF, et al
    Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophrenia.
    Schizophr Res. 2018;202:158-165.
    PubMed     Text format     Abstract available

  45. YAN C, Lui SSY, Zou LQ, Wang CY, et al
    Anticipatory pleasure for future rewards is attenuated in patients with schizophrenia but not in individuals with schizotypal traits.
    Schizophr Res. 2018 Dec 10. pii: S0920-9964(18)30690.
    PubMed     Text format     Abstract available


    Science

  46. GANDAL MJ, Zhang P, Hadjimichael E, Walker RL, et al
    Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder.
    Science. 2018;362.
    PubMed     Text format     Abstract available

  47. RAJARAJAN P, Borrman T, Liao W, Schrode N, et al
    Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk.
    Science. 2018;362.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: